|
US2015290199A1
|
|
Linagliptin solid dispersion
|
|
US2012270888A1
|
|
Pharmaceutical compositions of raltegravir, methods of preparation and methods of use therof
|
|
US2013273158A1
|
|
Extended release compositions of quetiapine
|
|
US2013259931A1
|
|
Oral pharmaceutical compositions of nebivolol and process for their preparation
|
|
US2014066468A1
|
|
Amorphous form of lopinavir and ritonavir mixture
|
|
US2013190368A1
|
|
Novel polymorphs of febuxostat
|
|
US2013237563A1
|
|
Polymorphs of pitavastatin calcium
|
|
US2011218204A1
|
|
Pharmaceutically acceptable salts of betulinic acid derivatives
|
|
US2013178654A1
|
|
Process for cinacalcet hydrochloride
|
|
US2011015196A1
|
|
Lupeol-type triterpene derivatives as antivirals
|
|
US2011313035A1
|
|
Polymorphs of darunavir
|
|
US2012215003A1
|
|
Process for the resolution of omeprazole
|
|
US2012107397A1
|
|
Pharmaceutical compositions of valsartan
|
|
US2012077772A1
|
|
Solid oral dosage forms of lamivudine
|
|
US2011237822A1
|
|
Process for preparation of valsartan intermediate
|
|
US2010227890A1
|
|
Polymorphs of esomeprazole salts
|
